Vaccine News and Research

Latest Vaccine News and Research

Edible egg-derived IgY antibodies against SARS-CoV-2 Omicron

A new study posted to the bioRxiv* preprint server reports on the development of anti-RBD immunoglobulin Y (IgY) antibodies from chicken eggs to block the binding of the viral RBD to human ACE2 receptors. This approach has several advantages since chicken egg-derived IgY can be edible and polyclonal can target multiple epitopes, enhancing neutralizing activity.

23 Feb 2022

Study on Omicron related mortality in cancer patients during recent COVID wave

A recent pre-proof study published in the journal Cancer Cell assessed the CFR of cancer patients during the third wave of the coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 Omicron variant.

23 Feb 2022

Genetics may influence how the body responds to vaccines and boosters

Genetics play an important role in how our bodies respond to vaccines and booster shots, suggesting that certain protective responses elicited by vaccination could be more effective with personalization, according to a new study led by University of Michigan researchers.

23 Feb 2022

Study explores the effectiveness of Moderna COVID-19 vaccine against omicron, delta variants

New Kaiser Permanente research published February 21, 2022 in Nature Medicine shows that while Moderna COVID-19 vaccine protection is strong against coronavirus infection by the delta variant, it is not as strong against infection from the omicron variant.

23 Feb 2022

Understanding the immune responses after secondary vaccinations with Pfizer and Moderna vaccines

In a new study, researchers assessed the serological responses to secondary booster doses of Pfizer's Comirnaty and Moderna's Spikevax COVID-19 vaccines.

23 Feb 2022

Study shows BCG vaccine provides no protection against SARS-CoV-2 in mice and hamsters

Researchers investigated the effectiveness of the BCG vaccines against SARS-CoV-2 infections using three animal models.

23 Feb 2022

SARS-Cov-2 reinfection in Syrian hamsters does not result in disease

Researchers have been investigating the reinfection of different SARS-CoV-2 variants in Syrian hamsters and found that this does not seem to result in disease or any significant pulmonary pathology.

23 Feb 2022

More evidence vaccines prevent ICU admission and mortality from SARS-CoV-2

In a recent study posted to the medRxiv* preprint server, researchers estimated the comparative virulence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between the vaccinated and unvaccinated subjects hospitalized with coronavirus disease 2019 (COVID-19) in Canada.

23 Feb 2022

SARS-CoV 2 Omicron prevalent in vaccine breakthrough cases in Bahia, Brazil

In a recent study posted to the medRxiv* pre-print server, researchers performed genomic monitoring to estimate the magnitude and range of the different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in SARS-CoV-2 reinfection cases among fully vaccinated individuals in Salvador, Bahia, Brazil.

23 Feb 2022

Low risk of second allergic reaction after SARS-CoV-2 vaccination

In a recent investigation posted to the journal JAMA Internal Medicine,* researchers estimate the risk of a repeated allergic reaction to the second severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine dose in those with a history of allergic responses following the first dose by conducting a systematic review and meta-analysis.

22 Feb 2022

Omicron neutralizing titers after third BNT162b2 dose are persistent

The new study, published in the journal Cell Host and Microbe, also finds that the neutralization against Omicron remains robust at four months after the third dose of the BNT162b2 vaccine.

22 Feb 2022

Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron

New research in nursing home residents found that a third dose of the Pfizer-BioNTech COVID-19 vaccine was effective for at least three months in protecting against the Delta and Omicron variant. While two doses of an mRNA COVID-19 vaccine showed poor neutralization to Omicron than Delta, a booster shot increased neutralizing antibody responses.

22 Feb 2022

Study of dental hygienists shows the profound impact of COVID-19 on clinical practice

Nearly two years into the pandemic with widespread availability of COVID-19 vaccines and a decrease in infections, new studies reveal dental hygienists have low COVID-19 infection rates and high vaccination acceptance.

22 Feb 2022

Poor sleep increases severity of viral respiratory infections including COVID-19

A new study explores the risk of respiratory infection with poor sleep in the context of the ongoing COVID-19 pandemic.

22 Feb 2022

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

Researchers explore the potential of mosaic receptor-binding domain nanoparticles in protective immunity against SARS-CoV-2

22 Feb 2022

New research focuses on improving the manufacturing process of lab-grown tissue from cells

Improving the way lab-grown tissue can be generated and organised from cells is the focus of new research from The University of Queensland.

22 Feb 2022

Unvaccinated students have eight times higher incidence of COVID-19 infection, study finds

Unvaccinated students had eight times the incidence of COVID-19 infection compared to vaccinated students in a North Carolina independent school, according to a study by the ABC Science Collaborative appearing online Feb. 22 in the journal Pediatrics.

22 Feb 2022

Vaccine News and Research

Latest Vaccine News and Research

Edible egg-derived IgY antibodies against SARS-CoV-2 Omicron

Study on Omicron related mortality in cancer patients during recent COVID wave

Genetics may influence how the body responds to vaccines and boosters

Study explores the effectiveness of Moderna COVID-19 vaccine against omicron, delta variants

Understanding the immune responses after secondary vaccinations with Pfizer and Moderna vaccines

Study shows BCG vaccine provides no protection against SARS-CoV-2 in mice and hamsters

SARS-Cov-2 reinfection in Syrian hamsters does not result in disease

More evidence vaccines prevent ICU admission and mortality from SARS-CoV-2

SARS-CoV 2 Omicron prevalent in vaccine breakthrough cases in Bahia, Brazil

Low risk of second allergic reaction after SARS-CoV-2 vaccination

Omicron neutralizing titers after third BNT162b2 dose are persistent

Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron

Study of dental hygienists shows the profound impact of COVID-19 on clinical practice

Poor sleep increases severity of viral respiratory infections including COVID-19

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

New research focuses on improving the manufacturing process of lab-grown tissue from cells

Unvaccinated students have eight times higher incidence of COVID-19 infection, study finds

SARS-CoV-2 Omicron variant rapidly takes over Delta viral strain in Norwegian households

REGEN-COV antibody combination to prevent COVID-19 severity

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in